Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myfortic Conversion in Renal Transplant Patients with GI Symptoms
NCT00676221Phase 4Unknown
- Start
- Jul 2006
- Primary completion
- Aug 2008
- Countries
- 1
01
Overview
Phase 4, open-label trial of mycophenolate sodium in kidney transplant rejection. Primary endpoint: Gastrointestinal Rating Scale at 12 weeks. Status: unknown.
02
Drugs
mycophenolate sodium
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00676221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00676221.